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Renal ischemia-reperfusion (IR) injury is the major cause of acute
renal failure in native and transplanted kidneys. Mononuclear leuko-
cytes have been reported in renal tissue as part of the innate and
adaptive responses triggered by IR. We investigated the participation
of CD4+ T lymphocytes in the pathogenesis of renal IR injury. Male
mice (C57BL/6, 8 to 12 weeks old) were submitted to 45 min of
ischemia by renal pedicle clamping followed by reperfusion. We
evaluated the role of CD4+ T cells using a monoclonal depleting
antibody against CD4 (GK1.5, 50 µ, ip), and class II-major histocom-
patibility complex molecule knockout mice. Both CD4-depleted groups
showed a marked improvement in renal function compared to the
ischemic group, despite the fact that GK1.5 mAb treatment promoted
a profound CD4 depletion (to less than 5% compared to normal
controls) only within the first 24 h after IR. CD4-depleted groups
presented a significant improvement in 5-day survival (84 vs 80 vs
39%; antibody treated, knockout mice and non-depleted groups,
respectively) and also a significant reduction in the tubular necrosis
area with an early tubular regeneration pattern. The peak of CD4-
positive cell infiltration occurred on day 2, coinciding with the high
expression of ßC mRNA and increased urea levels. CD4 depletion did
not alter the CD11b infiltrate or the IFN-γ and granzyme-B mRNA
expression in renal tissue. These data indicate that a CD4+ subset of T
lymphocytes may be implicated as key mediators of very early
inflammatory responses after renal IR injury and that targeting CD4+
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Introduction
Ischemia-reperfusion (IR) injury is in-
evitably associated with the retrieval, stor-
age and transplantation of solid organs, es-
pecially with grafts from deceased donors
(1). IR injury adversely affects early renal
graft function and contributes to the devel-
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opment of chronic allograft nephropathy
(2,3). Furthermore, in native kidneys, mor-
tality of patients with ischemic acute renal
failure has remained high over the last 50
years despite enormous advances in sup-
portive care (4). Currently, there is no effec-
tive therapeutic approach to limit IR, so that
knowledge of its pathophysiology is crucial
to devise effective strategies.
Many studies have shown that the inflam-
matory response induced by ischemia fol-
lowed by reperfusion is largely responsible for
the tissue damage, consequently leading to
functional organ failure (3,5-7). This acute
inflammatory response is characterized by the
induction of a pro-inflammatory cytokine cas-
cade (8), enhanced expression of adhesion
molecules (5,8), up-regulation of the major
histocompatibility complex (MHC) antigens,
and cellular infiltration (5-7,8,9). However,
the specific mechanism involved in inflam-
mation-mediated IR injury is still a matter of
debate (1,9). Neutrophils have long been re-
lated to the ischemic tissue damage. The inhi-
bition of neutrophil migration and even their
activation have been demonstrated to have a
protective effect on renal IR (5,9). However,
these data were not unanimously accepted and
the role of neutrophils in tissue aggression is
currently considered to be less important (9,10-
12).
On the other hand, there is some evi-
dence implicating lymphocytes as important
mediators in IR injury. Notwithstanding the
presence of T lymphocytes in ischemic tis-
sues (7,11,12), the mechanisms involved in
tissue injury are not known.
The idea that T lymphocytes are impor-
tant in IR came from classical studies on
biopsies from patients with acute ischemic
renal failure where mononuclear cells pre-
dominated in the vasa recta (13). Further-
more, the production of T cell-associated
cytokines and chemokines has also been
well documented at sites of experimental
renal IR damage (7,8,10). Blockade of leu-
kocyte adhesion molecules such as intercel-
lular adhesion molecule-1 and CD11/CD18
promotes substantial reduction of IR injury
(5,14). Moreover, blockade of the CD28-B7
co-stimulatory pathway with CTLA4-Ig or
anti-B71 antibody significantly reduces re-
nal dysfunction after IR in rats (7,11,15,16).
The use of gene-targeted knockout mice has
brought more detailed information about the
role of T cells in this context. CD4+ and
CD8+ T cell double-knockout mice, nu/nu
mice (deficient in T cells) and CD4-knock-
out mice are all protected from renal IR
injury (17,18). Furthermore, adoptive trans-
fer of naive CD4 T cells into these mice
reconstituted the injury profile, which was
mainly dependent on interferon-γ (IFN-γ)
and CD28 pathways (18).
Therefore, it is well accepted that IR is
an orchestrated event involving innate and
adaptive immune responses (12). The am-
plification of the immune response as an
early event might elicit a strong T cell action
that ultimately results in extension of the
tissue injury. We hypothesized that the early
initial phase post-IR injury is a critical mo-
ment of T cell activation contributing to the
pathophysiology of acute renal damage. We
addressed this issue in a murine model of
renal IR injury, in which the animals under-
went acute and transient CD4 T cell deple-
tion. Additionally, class II MHC knockout
mice, which are naturally CD4+ T cell de-
pleted, were also used in the experiments.
We investigated the profile of histological




The following antibodies were used in
fluorescence-activated cell sorting (FACS)
experiments: anti-CD3 (clone 145-2C11, ham-
ster anti-mouse IgG1, fluorescein 5-isothiocy-
anate), anti-CD4 (RM-5, rat anti-mouse IgG2b,
phycoerythrin), all purchased from Pharmin-
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gen (San Diego, CA, USA). For immunohis-
tochemistry, the primary biotinylated mono-
clonal antibodies (mAb) used were GK1.5 (rat
anti-mouse CD4) and M1/70 (rat anti-mouse
CD11b-macrophages, natural killer (NK) cells
and dendritic cells) (Pharmingen).
Animals
Isogenic male C57BL/6 mice (H2b) were
obtained from the Institute of Pharmacolo-
gy, Universidade Federal de São Paulo. MHC
class II Ab-deficient mice were purchased
from Taconic Farms (Germantown, NY,
USA). These mice were derived by homolo-
gous recombination in embryonic stem cells
as described (19). They exhibit depletion of
CD4+ T cells by the disruption of the Aß
(H2b) gene. The animals were 8-12 weeks
old and weighed 25-28 g. All animals were
housed in individual standard laboratory
cages and had free access to water and food.
Depletion of CD4+ cells
A purified mAb against L3T4 (GK1.5,
rat IgG2b) was purchased from Pharmingen
and selected mice were injected with a single
dose of 50 µg ip 48 h before IR. CD4+
lymphocyte depletion by anti-CD4+ T cell
mAb was confirmed by FACS analyses of
splenocytes on days +1, +2 and +3 post-
treatment, corresponding to the day of pedicle
clamping, 1 and 2 days after reperfusion,
respectively. The anti-CD4 treatment pro-
moted a profound depletion of CD4+ T cells
from the splenocyte population compared to
untreated animals. At the time of pedicle
clamping, 48 h after the administration of
antibodies, 96.9 ± 1.8% of CD4+ cells were
depleted compared to control animals. Three
and 4 days after GK1.5 administration (24
and 48 h after pedicle clamping) there was a
partial splenic repopulation, and the deple-
tion was 68.5 ± 2.1 and 66.7 ± 6.3% in
matched controls. The MHC class II knock-
out animals had only 3.6% of CD4+ T cells in
the splenocyte population (depletion of 96.5
± 0.7%). A schematic summary of FACS
results is shown in Figure 1. The FACS
analyses were carried out in a Becton Dick-
inson FACScalibur (Mountain View, CA,
USA) and the results analyzed with Cell
Quest program (Becton Dickinson).
Ischemia-reperfusion model and protocol
Surgery was performed as described (5).
Briefly, mice were anesthetized, placed on a
surgical table and heated by indirect illumi-
nation. A midline abdominal incision was
made and both renal pedicles were cross-
clamped for 45 min. Both kidneys were in-
spected after 2 min to confirm the change in
color and thus ischemia. The abdomen was
filled with 500 µL of prewarmed sterile sa-
line solution just before being temporarily
closed. The abdomen was reopened and the
microsurgery clamps were removed. The
kidneys were inspected for complete resto-
ration of blood flow and 500 µL of prewarmed
sterile saline was again instilled into the
abdomen. The abdomen was closed, and the
animals were placed in heated cages until
complete recovery from anesthesia, with free
access to water and food. Animals were
divided into four groups: group 1 (G1, N =
9), surgery without pedicle clamping (sham);
group 2 (G2, N = 25), 45 min of ischemia
followed by reperfusion; group 3 (G3, N =
28), animals submitted to IR and treated
with 50 µg GK1.5 48 h before the procedure,
and group 4 (G4, N = 10), genetically de-
pleted animals submitted to IR. Group 1, 2
and 3 mice were killed 1, 2 and 5 days after
surgery. In group 4, because of the limited
number of animals available, we decided to
evaluate the points of major renal injury (2
days) and the point of almost recovery (5
days). At that time, blood was collected for
urea measurement and kidney tissue was
harvested for histological study and messen-
ger RNA (mRNA) analysis. All procedures
were carried out with the approval of the
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fields, 200X) per specimen was analyzed in
four animals per group. A tubular necrosis
pattern was assigned when there was a loss
of membrane and nuclear integrity, loss of
brush border, vacuolization of tubular epi-
thelial cells, or the presence of intratubular
debris. Regeneration profiles were assigned
when we observed soft nuclear chromatin,
nucleus of various shapes and volumes, many
nucleoli per nucleus, and a less basophilic
cytoplasm (13).
Immunohistochemistry
Surgically removed kidney sections were
snap frozen in liquid nitrogen and embedded
in Histo Prep (Fisher Diagnostics, Fair Lawn,
NJ, USA). Thin frozen sections (5 µm) were
cut and fixed in 2% methanol. The binding
of mAb was detected by the avidin-biotin/
alkaline phosphatase method as described
(20). We used proliferating cell nuclear anti-
gen (PCNA) identification to identify cells
undergoing the proliferating phase. For this
purpose paraffin sections were prepared as
described (20). As the PC10-EPOS antibody
obtained from Dako (Dako A/S, Glostrup,
Denmark) is conjugated with peroxidase,
sections were directly incubated with amino-
ethyl-carbazole (Sigma, St. Louis, MO,
USA). Labeled cells in the outer medulla in
20 consecutive, non-overlapping fields per
mouse, were counted in 3 animals per group
using the same computed image system as
used for histological evaluation. For PCNA
analysis we measured fields of 200X and of
400X for CD4+- and CD11b-positive cells.
All sections were evaluated blindly.
Reverse transcriptase-polymerase chain
reaction
Kidney samples were quickly frozen in
liquid nitrogen immediately after surgical
excision under sterile conditions. Total RNA
from renal tissues was extracted using TRIzol
LS reagent (Life Technologies, New York,
Research Ethics Committee of Universidade
Federal de São Paulo.
Renal function
Blood samples (400 µL) were collected
by retro-orbital puncture under general an-
esthesia. Serum urea measurements were
performed in duplicate by the urease method
using a Cobas Mira Plus autoanalyzer (Roche,
Mannheim, Germany).
Mortality
Mortality is reported as percentage of
deaths in comparison to the total number of
animals submitted to the surgical procedure
in each group at two times (days 1 and 2 after
surgery). Survival curves were used to re-
port mortality five days after the IR proce-
dure.
Histological examination
After surgical removal, kidneys were cut
coronally, fixed in Bouin solution followed
by 10% buffered formalin and embedded in
paraffin. Sections (4 µm) were stained with
hematoxylin-eosin. The extent of tubular
morphology patterns of necrosis and regen-
eration in the outer medulla was examined
by blinded morphometry assessment using a
computed-assisted image system with an
Olympus BX40F-3 microscope (Olympus
Optical Company, Tokyo, Japan) and the
Image Pro Plus for Windows 3.0 software
(Media Cybernetic, Silver Spring, MD,
USA). After image capture by this system,
the morphometric quantitative analysis was
performed with the Image Lab software (Im-
age Lab, São Paulo, SP, Brazil). In these
studies, the area of necrosis or regeneration
was traced by computed-assisted morphom-
etry and the results are reported as percent
necrosis or regeneration in the total area
(0.073 mm2) of the 200X field of view. For
this purpose, a total area of 1.46 mm2 (20
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NY, USA) according to the manufacturer’s
protocol. Three animals per group were
evaluated for each time point. mRNA was
extracted from total RNA using the Quick-
Prep Micro mRNA Purification kit (Amer-
sham Pharmacia Biotech Inc., Piscataway,
NJ, USA) following manufacturer instruc-
tions. Samples of 100-200 ng of kidney
mRNA and PHA- and PMA-stimulated
spleen cell mRNA (as external control) were
added to oligo d(T), and a reverse transcrip-
tase reaction was carried out with nucleo-
tides dATP, dCTP, dGTP, DTTP (10 mM
each), and M-MLV reverse transcriptase
(Gibco BRL Life Technologies, Gaithers-
burg, MD, USA) (21). Primers were con-
structed based on published sequences for
the constant-conserved residues of ß-chain
(ßC) as a marker of the presence of T cells
and for IFN-γ and granzyme B as products
related to T cell function and for ß-actin as
an internal control of the presence and qual-
ity of mRNA (21). A polymerase chain reac-
tion (PCR) assay was performed with cDNA,
2.5 U of Taq polymerase (Gibco) and specif-
ic primers for a 50-µL final reaction. Forty
cycles of amplification were performed. Each
cycle consisted of 1 min at 94ºC for denatur-
ation, a specific annealing cycle (45 s at
55ºC for ß-actin and ßC, 45 s at 57ºC for
granzyme B, and 30 s at 53ºC for IFN-γ) and
45 s of 72ºC for extension, followed by a
final incubation at 72ºC for 10 min. PCR
conditions were standardized for sensitivity,
reliability and specificity with the negative
and positive controls. The PCR product was
run on 2% agarose gel stained with fluores-
cent dye (Sybr Green, Molecular Probes,
Eugene, OR, USA). The gels were scanned
to estimate relative band intensity using a
Storm™ fluorescent optic scanner and Im-
age Quant 4.0 software (Molecular Dynam-
ics, Sunnyvale, CA, USA). RNA was esti-
mated semi-quantitatively with ß-actin (ßC,
IFN-γ) or ßC (granzyme B) as internal con-
trol. The results are reported as arbitrary units,
expressing the rate of the gene densities com-
pared to the internal control (ß-actin or ßC).
Statistical analysis
Data are reported as means ± SD (para-
metric variables) or median and range when-
ever appropriate. Different evolutions were
compared between groups by ANOVA fol-
lowed by the Student-Newman-Keuls or
Dunn test for individual comparisons be-
tween groups. The mortality rates at 1 and 2
days after IR were compared by Fisher exact
test. Five-day Kaplan-Meier survival curves
were compared by the log-rank test. The
level of significance was set at P < 0.05 for
all analyses.
Results
Transient depletion of CD4+ T cells
promoted renal function protection after
ischemia-reperfusion
To demonstrate the importance of CD4+
T cells in the inflammatory events of post-
reperfusion we compared a chronic and sus-
tained depletion of CD4+ T cells with an
acute, profound, but transient depletion. Mice
treated with a single 50-µg dose of purified
GK1.5 mAb were successfully depleted of
CD4+ T cells 48 h thereafter (population of
3.1%), specifically at the time when renal
pedicles were clamped (Figure 1). This de-
Figure 1. Depletion of spleno-
cyte CD4+ cells. Treatment with
GK1.5 mAb (filled columns) pro-
moted a significant reduction of
CD4+ cells (to 3.1%) compared
to control (open columns) during
mouse ischemia-reperfusion (IR)
episode. A subsequent partial
repopulation of CD4+ cells (26
and 38%) occurred on the 2nd
and 3rd days after IR injury.
CD4+ splenocyte counts in MHC
class II knock-out mice (MHC II
KO; 3-4%, grey bars) were simi-
lar to those of GK1.5-treated
mice at the time of IR. The varia-
tion in the values of the control
wild-type mouse used as refer-
ence was less than 2%. N = 3 in
each group. *P < 0.001 for the
GK1.5 group and MHC II KO
group vs control group on day of
IR. **P < 0.01 for the GK1.5 and
MHC II KO groups vs the control
group on 2nd and 3rd days after
IR (Student t-test).
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gree of depletion is similar to those achieved
in renal transplantation in order to prevent
acute rejection and was also reported to pro-
tect animals from IR injury (22). GK1.5
mAb-treated animals had a partial reconsti-
tution of the CD4+ T cell population on days
1 and 2 after reperfusion, ranging from 26 to
38% of the values observed in matched con-
trols. In contrast, MHC class II knockout
mice, genetically deficient in CD4+ T cells
by negative thymic selection, exhibited a
sustained CD4+ T cell depletion (population
of 3-4%), similar to that seen in GK1.5
mAb-treated animals on the day of IR.
Forty-five minutes of ischemia followed
by reperfusion caused a marked decrease in
renal function as assessed by urea levels in
wild-type mice. One day after IR, the ani-
mals had a significant increase in blood urea
levels as compared to sham-operated ani-
mals (354.5 ± 109.1 vs 61.1 ± 10.7 mg/dL, P
< 0.05). This increase in blood urea peaked
on the second day after IR, with an important
recovery on day 5. CD4+ T cell-depleted
animals, that had a depletion of the CD4+ T
cell population, had lower levels of urea on
day 1 (G3 - anti-CD4 treated, 215.2 ± 155.9
vs G2 - IR animals, 354.5 ± 109.1 mg/dL, P
< 0.05) and on day 2 (G3, 199.4 ± 195.9 and
G4 - anti-CD4 treated and genetically de-
pleted, 156.3 ± 79.2 vs G2, 396.1 ± 86.1 mg/
dL, P < 0.05), when compared to IR animals.
Two days after IR injury, although G3 had a
partial repopulation of CD4+ T cells (deple-
tion of 68.5 ± 2.1%) compared to knockout
mice (depletion of 96.5 ± 0.7%), renal func-
tion did not differ between them. Five days
after IR, there was no difference among the
four groups (Figure 2).
Transient CD4+ T cell depletion was
associated with increased animal survival
after ischemia-reperfusion
This model of IR injury is accompanied
by severe acute renal failure that can be
indirectly measured by mouse mortality. The
Figure 2. Effect of CD4+ cell depletion on renal function
(urea) after ischemia-reperfusion (IR). Animals of the
CD4+-depleted groups treated with GK1.5 (filled tri-
angles, N = 8 on day 1, N = 9 on day 2 and N = 11 on
day 5), and MHC class II knock-out (MHC II KO) ani-
mals (open triangles, N = 6 on day 2 and N = 4 on day
5) produced less urea than the ischemic group (filled
squares, N = 9 on day 1, N = 8 on day 2 and N = 8 on
day 5) after the same IR injury 1 and 2 days after
reperfusion. Sham group (open squares, N = 3 on each
point). Blood samples were obtained at sacrifice and
each point represents a separate group of mice. *P <
0.05 for the GK1.5 group vs the ischemic group on day
1. **P < 0.05 for the GK1.5 and MHC II KO groups vs
the ischemic group on day 2 (ANOVA test with Stu-
dent-Newman-Keuls correction).
Figure 3. Effect of ischemia-reperfusion (IR) on survival
of normal (C57BL/6, dashed line with squares) and
CD4+ cell-depleted animals (GK1.5 treated, triangles,
and MHC II knock-out (MHC II KO), circle). The anti-
CD4-treated group showed a better survival compared
to the ischemic group (P < 0.01) whereas the MHC II
KO group showed an improved survival (80.0%), but
without statistical significance. Five-day survival curves
were calculated by the Kaplan-Meier method and com-
pared by the log-rank test. All sham-operated animals
survived the experiment (black line without symbols).
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mortality rate at 1 and 2 days after reperfu-
sion was less than 10%, and did not differ
among groups. However, 45 min of ische-
mia was accompanied by a high-mortality
rate in the ischemic group (G2) at 5 days
after reperfusion. Five-day animal survival
increased in antibody-depleted animals (G3,
84%), and in class II MHC KO mice (G4,
80%), in contrast to 39% in the ischemic
group (P < 0.01). The survival of CD4+ T
cell-depleted groups was statistically similar
(P = 0.73). None of the animals in the sham
group died, suggesting that the surgical pro-
cedure was not a cause of death in the model
(Figure 3).
The absence of CD4+ T cells was associated
with less acute tubular injury and an early
tubular regeneration pattern after ischemia-
reperfusion
In contrast to acute renal failure in hu-
mans, when marked morphological features
of tubular necrosis are frequently dissoci-
ated from the degree of renal dysfunction, in
mice, 45 min of renal ischemia promoted
extensive tubular necrosis in the outer me-
dulla, as can be seen in Figure 4, panel A.
The renal function protection seen in ani-
mals in which the CD4+ T cell population
was absent was mirrored by histological
changes in kidney sections on days 1 and 2.
As shown in Figure 4, panel A, on day 2
untreated animals exhibited massive tubular
necrosis and obstruction, which were much
reduced when the animals were pretreated
with GK1.5 (panel B) or in class II MHC KO
mice. At this point, in the ischemic group
(G2), tubular massive necrosis was predomi-
nant, while CD4+ T cell-depleted animals
showing necrotic changes mixed with early
regeneration patterns.
Using an accurate morphometric analy-
sis of renal cross-sections, we were able to
quantify these differences. One day after
reperfusion, the area occupied by necrotic
changes in the outer medulla was 67.3% of
the total area measured (1.4 mm2 in 20 fields
of view) in G3, significantly smaller than the
area of 78.2% in the ischemic group (P <
0.05). On day 2, both depleted groups, G3
(37.2%) and G4 (60.3%), also had a signifi-
cant reduction in the tubular necrosis area
compared to G2 (77.6%, P < 0.05) (Figure 5,
panel A).
Another striking difference between
CD4+ T cell-depleted (G3 and G4) and non-
depleted ischemic animals after IR injury
was the pattern of tubular regeneration, which
occurred much earlier in the two depleted
groups than in non-depleted ischemic ani-
mals (G2). By morphometric analysis we
detected this regenerative pattern in G2 only
on day 5 (70.7% of the total area analyzed).
In contrast, in the GK1.5 mAb-treated group
(G3), a tubular regeneration area was al-
ready present and larger than that of the
ischemic group on day 1 after IR (32.6 vs
6.7%, respectively, P < 0.05). On day 2, we
observed extensive areas of tubular regen-
eration in G3 (43.2%) and G4 (39.6%), again,
Figure 4. Effect of CD4+ cell de-
pletion on renal histology after
45 min of ischemia followed by
reperfusion. Light microscopy of
representative kidney sections,
H&E, 200X. Comparison of ani-
mal from the ischemic group (A)
and animal treated with anti-
CD4 mAb (B). Note extensive
tubular necrosis (black arrows)
in A, attenuated in B, and ab-
sence of regeneration changes
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we demonstrated PCNA-positive cells on
days 1 (median of 53 cells/field) and 2 (34
cells/field) when the morphologic patterns
of tubular regeneration were absent. These
patterns greatly increased on day 5 (126
cells/filed). In contrast, the CD4+ T cell-
depleted groups (G3 and G4) presented a
significantly higher number of PCNA-posi-
tive cells on days 1 (G3 - 79 cells/filed) and
2 (G3 - 90.5 cells/field, G4 - 88.5 cells/field)
in comparison to G2, similar to what was
seen for tubular regeneration by morpho-
metric analysis. In fact, PCNA staining of
proliferating nuclei showed a positive corre-
lation with the morphometric analysis of
tubular regeneration (R = 0.74, P < 0.0001).
In the sham group, necrotic and regeneration
changes were minimal.
In conclusion, in transient or sustained
absence of CD4+ T cells, ischemic kidneys
led to less tubular necrosis and displayed an
early tubular regeneration signal, detected
by morphometric and PCNA staining analy-
ses.
Infiltration of CD4+- and CD11b-positive
cells in renal tissue after ischemia-reperfusion
Kidney tissues from sham-operated ani-
mals stained poorly for CD4 or CD11b mark-
ers. After 1 and 2 days of reperfusion, an
increased number of interstitial infiltrating
CD11b-positive cells was found in the outer
medulla in all groups subjected to IR. They
significantly differed from the sham group
but not amongst themselves, regardless if
they were CD4+ T cell-depleted or not (Fig-
ure 6, panel A). Five days after ischemia,
knockout animals had a decreased number
of infiltrating CD11b-positive cells (9 cells/
field) compared to ischemic (24 cells/field)
and GK1.5 mAb-treated (23.5 cells/field)
groups (P < 0.05).
IR injury resulted in infiltration of CD4-
positive cells in the renal tissue mainly on
the second day after the insult (Figure 6,
panel B). In contrast, in CD4+ T cell-de-
Figure 5. Morphometric analysis of tubular necrosis (A) and regeneration (B)
areas in the outer medulla. A, CD4+ cell-depleted groups showed less extensive
tubular necrosis than the ischemic group. B, Regeneration changes appeared
early in groups in the anti-CD4+ mAb-treated and MHC II knock-out (MHC II KO)
groups. Data are reported as percent as medians of 20 fields of each kidney
section at magnification of 200X. H&E. IR = ischemia-reperfusion. *P < 0.05 for
the ischemic group vs the GK1.5-treated group (ANOVA on ranks test, Dunn
correction); **P < 0.05 for the ischemic group vs the GK1.5-treated and MHC II
KO groups (ANOVA on ranks test, Dunn correction).
much larger than those observed in the is-
chemic group (2.7%, P < 0.05). The is-
chemic group showed large areas of tubular
regeneration only on day 5 (70.7%), which
were larger than those observed in G3
(39.9%) and G4 (60.5%, P < 0.001 (Figure
5, panel B).
Tubular cell proliferation determined by
PCNA staining was broadly disseminated in
the outer medulla, exactly in the same area
of tubular injury. In the ischemic group (G2),
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pleted animals (G3), this infiltration was
delayed to three days, coinciding with the
peripheral repopulation of CD4+ T lympho-
cytes. On day 2, when IR animals (G2) had
an increased degree of tubular necrosis and
increased renal dysfunction, groups 3 and 4
(depleted groups) showed the lowest levels
of infiltrating CD4+ T cells in inflamed renal
areas.
Gene transcript analyses in renal tissue after
ischemia-reperfusion injury
Although substantial data in the litera-
ture indicate a role for T cells in IR injury,
the mechanisms implicated are unclear re-
garding the action of cytokines. CD4+ T cells
can provide help to CD8+ T cells that ulti-
mately can become cytotoxic and to macro-
phages and NK cells, amplifying the im-
mune response to self-tissues. Thus, we also
investigated the role of the Th1 cytokine,
IFN-γ, and the CD8+ T cell-related cytolytic
molecule, granzyme B. In addition, we ana-
lyzed the constant domain of the ßC as a
marker of the presence of T cells. Gene
expression of the constant domain of the ßC,
IFN-γ and granzyme B was semi-quantified
by RT-PCR in renal tissue, normalized
against an internal control, ß-actin (for ßC
and IFN-γ) or ßC (granzyme B).
In the ischemic group, a high expression
of ßC mRNA was detected on day 2 after IR
injury (0.19 arbitrary units vs 0.006 and 0.06
on days 1 and 5, respectively). In the CD4+ T
cell-depleted groups, its level was hardly
detected (all behind the level of 0.1 arbitrary
units). This profile of ßC mRNA expression
in the ischemic group correlated with the
CD4 staining seen by immunohistochemis-
try, both peaking on day 2.
Despite the CD4+ T depletion, there were
no significant changes in IFN-γ mRNA ex-
pression in the three groups submitted to IR,
but these groups exhibited higher values of
IFN-γ mRNA than those detected in sham
animals. Granzyme B mRNA expression was
quite similar in all groups. They all showed
a progressive increase in its levels from day
1 (0.23 units in ischemic group, 0.66 units in
GK1.5-treated group), achieving the highest
values on day 5 (0.81, 0.99, 0.88 units in
ischemic, GK1.5-treated and MHC class II
knock-out groups, respectively).
Discussion
CD4+ T cell infiltration has been well de-
scribed in post-ischemic tissues (6-8,11,23,24)
but there are very few studies directly demon-
Figure 6. Immunohistochemistry of CD11b (A) and CD4+ (B) cells. A, On day 2,
groups submitted to renal ischemia exhibited more CD11b-positive cells than the
sham group (*P < 0.05); on day 5 the knockout group had fewer positive cells
than the ischemic and anti-CD4+-mAb-treated group (**P < 0.05). B, Ischemic
group showed more CD4-positive cells than other groups on day 2 (+P < 0.05).
IR = ischemia-reperfusion. *P < 0.05, sham vs the ischemic, GK1.5 and knock-
out groups; **P < 0.05, knockout group vs ischemic and GK1.5 group; +P < 0.05,
ischemic vs other groups (ANOVA on ranks test, Dunn correction).
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strating the role of T lymphocytes in renal IR
injury. Better long-term survival and less acute
and chronic renal dysfunction have been re-
ported after blockade of the B7:CD28/CD152
pathway (7,11,15,16) in a rodent IR model.
Rabb et al. (17) found diminished renal im-
pairment in a model of 30-min ischemia fol-
lowed by reperfusion in mice genetically defi-
cient in CD4+ and CD8+ T lymphocytes. Re-
cently, the same group showed that reconstitu-
tion with CD4+ T cells in CD4+ T cell knock-
out mice reversed this effect (17,18). These
studies and our data indicate that mainly CD4+
T cell subsets play a key role in renal injury
following IR.
In the present study, we demonstrated a
substantial reduction of renal IR injury in
CD4+ T cell-depleted mice compared to wild-
type normal mice. The acute and transient
depletion with GK1.5 mAb promoted similar
results in genetically CD4+ T cell-depleted
mice, even with incomplete depletion 24 and
48 h after the insult, emphasizing the impor-
tance of a T cell subset in this very early
phenomenon. Protection from renal IR injury
by CD4+ T cell depletion was demonstrated by
lower levels of serum urea and higher survival
5 days after IR in the depleted groups (G3 and
G4) compared to IR mice (G2). This increased
animal survival in CD4+ T cell-depleted mice
is probably due to a less serious impairment of
renal function, since there were no deaths in
sham-control mice.
We also quantitatively assessed the in-
tensity of tubular necrosis and regeneration
at both time points in the outer medulla,
where the nephron segments most affected
by IR injury are located. The CD4+ T cell-
depleted groups had significantly less tubu-
lar injury in the outer medulla than normal
mice since a smaller area of tubular necrosis
and regeneration changes were present ear-
lier after IR. This early regeneration profile
was confirmed by a greater number of PCNA-
positive cells in CD4+ T-depleted cells when
compared to untreated control IR mice. The
tubular regeneration pattern is not frequently
exploited in experimental IR studies. It was
possible to do in our study because we in-
cluded day 5 after the reperfusion, when we
could evaluate mice that survived to IR epi-
sode. Marques et al. (25) also demonstrated
that in Th1-immune response-deficient mice,
in the same model of renal IR, the attenuated
tubular injury was linked to a precocious
tubular regeneration.
As demonstrated by immunohistochem-
istry, CD4-positive cellular infiltration was
greater on day 2 after reperfusion, coincid-
ing with a higher expression of Cß mRNA
and peak urea levels in the ischemic group.
This pattern is consistent with the studies by
De Greef et al. (11) and Ysebaert et al. (24)
using rat models of renal IR injury. In those
studies T cell infiltration in the outer stripe
of the outer medulla peaked after 24 h, also
coinciding with the highest creatinine levels
after IR. The CD11b-positive cell infiltrate
(macrophages, NK cells and dendritic cells)
in the post-ischemic kidney was not signifi-
cantly affected by CD4+ T cell depletion in
our mouse IR model. Burne et al. (18) re-
ported similar results in CD4+ T cell-defi-
cient mice, i.e., they found no significant
difference in the amount of macrophages or
neutrophils infiltrating the kidney after 30
min of renal ischemia. These data support
the hypothesis that CD4+ T cells act on IR
injury despite recruitment and infiltration of
this kind of inflammatory cells.
The increase in the expression of IFN-γ
mRNA in kidney tissues after IR injury has
been described by others (6,8,9,26). In our
study, CD4+ T cell depletion, in addition to
attenuating renal dysfunction, did not sig-
nificantly alter the intensity of IFN-γ mRNA
expression. This suggests that IFN-γ mRNA
up-regulation in post-ischemic tissue is not
directly linked to renal injury. In vivo neu-
tralizing IFN-γ with mAbs reduced MHC
molecule expression but produced no im-
provement in renal dysfunction in a 60-min
model of renal ischemia (26). Yokota et al.
(27) also found no improvement in renal
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dysfunction in IFN-γ knockout mice submit-
ted to 35 min of ischemia. NK or T cells may
be responsible for production of IFN-γ after
tissue injury. Our results suggest that NK
cells may be responsible for the production
of IFN-γ since IFN-γ persisted in a CD4+ T
cell-depleted milieu and the abrogation of
renal injury occurred independently of the
IFN-γ levels. The expression of granzyme B
mRNA, a measure of cytotoxic effector
mechanisms by CD8+ T lymphocytes, was
similar in the groups studied, supporting the
fact that renal IR injury is independent of
this cell population (18,24).
The pathways by which T cells might
mediate renal IR injury are not easily deter-
mined on the basis of concepts of classical
immunology. T cell activation is a manda-
tory step in T cell-dependent immune re-
sponses. Activation of naive T cells has tra-
ditionally been demonstrated to require rec-
ognition by T cell receptors of a foreign
antigen bound to self-MHC molecules in the
presence of appropriate co-stimulatory sig-
nals by an antigen-presenting cell. We could
not investigate this in our study because we
cannot easily detect any foreign antigen pres-
ent in renal IR injury that would activate T
cells by classical pathways. Self-molecules
could be modified due, for example, to oxi-
dation by reactive oxygen species produced
during the IR injury process (28), and their
modified structure could then be recognized
as foreign by the immune system (3,23). In
the absence of an appropriate antigen, acti-
vation of T lymphocytes might occur via an
antigen-independent pathway. The chemo-
kine RANTES has been shown to directly
activate T cells (29,30). Since RANTES up-
regulation has already been described in post-
ischemic renal tissue (7,31,32) and its block-
ade has attenuated renal IR dysfunction (10),
direct activation of T cells by RANTES may
be an attractive mechanism of renal IR in-
jury. Another hypothesis, introduced by the
“danger model”, assumes that driving forces
for an immune response are not the recogni-
tion of foreign antigens but the recognition
of danger (33). The tissue relays alarm sig-
nals to the local sentries, the antigen-pre-
senting cells, to initiate immune responses.
Some experimental studies have already in-
vestigated these mechanisms in models of
IR injury (34,35).
The most striking result revealed by our
study is the important reduction of IR injury
quite similar in the acute and in the geneti-
cally CD4+ T cell-depleted animals. The
MHC class II knockout animals have an
established CD4+ T cell depletion greater
than 95%. Since the GK1.5 mAb-depleted
group was profoundly deficient in CD4+ T
cells (less than 5% of normal) as early as
during the first 24 h after the IR insult, this
early period may be considered to be the
critical phase when CD4+ T cells participate
in the IR injury process. In view of the time
necessary for the specific T cell immune
response to occur and our results indicating
unchanged CD11b infiltration and unmodi-
fied mRNA expression of granzyme B and
IFN-γ, it appears that CD4+ T cells can par-
ticipate in IR injury in a non-antigen-specif-
ic way. De Greef et al. (11) also clearly
demonstrated T cell adherence a few hours
after IR in the outer medulla post-capillary
venules of ascending vasa recta, possibly
acting by physical obstruction of these ves-
sels and contributing to vascular congestion
and the “no-reflow” phenomenon. The block-
ade of the CD28-B7 co-stimulatory pathway
was able to neutralize this T cell adherence
and to reduce renal impairment after IR.
The present study shows that an acute
and transient CD4+ T lymphocyte depletion
significantly limited renal dysfunction, mor-
tality and tubular injury in a mouse model of
IR, similar to what is observed in chronic
and sustained long-term CD4+ T cell deple-
tion. These findings implicate a CD4+ subset
of T lymphocytes as key mediators of early
inflammatory responses after renal IR in-
jury. It is not known if T cells act by mediat-
ing or amplifying renal injury.
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